BOX-BEHNKEN DESIGN ASSISTED ECO-FRIENDLY RP-HPLC-PDA METHOD FOR THE QUANTIFICATION OF PACLITAXEL: APPLICATION TO EVALUATE THE SOLUBILITY OF PACLITAXEL-CYCLODEXTRIN COMPLEX

ASHUTOSH GUPTA; RIMA V. KOSSAMBE; SUDHEER MOORKOTH

doi:10.22159/ijap.2024v16i6.51690

Authors

ASHUTOSH GUPTA Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India https://orcid.org/0000-0003-4236-6580
RIMA V. KOSSAMBE Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India https://orcid.org/0009-0009-6174-9131
SUDHEER MOORKOTH Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India https://orcid.org/0000-0002-5341-0981

DOI:

https://doi.org/10.22159/ijap.2024v16i6.51690

Keywords:

Paclitaxel\, HPLC, Design of experiment, Cyclodextrin complex, Solubility

Abstract

Objective: Paclitaxel (PTX) is one of the oldest chemotherapeutic agents for cancer treatment. However, PTX is a class IV drug under the Biopharmaceutical Classification System (BCS), and its oral administration is restricted due to its low bioavailability. Complexing PTX with Beta-Cyclodextrin (β-CD) is an option to overcome the low solubility and bioavailability. This study aims to optimize and develop an RP-HPLC analytical method for quantifying PTX from the fabricated β-CD complex.

Methods: The HPLC settings were optimized using Design-of-Experiments (DOE) software. The independent variables for the optimization process were buffer ratio, buffer pH, flow rate, and injection volume. The responses were Retention Time (RT), peak area, Tailing Factor (TF), and number of Theoretical Plates (TP) of PTX. The validated method was then used to measure the % entrapment from the PTX- β-CD complex.

Results: The developed and optimized RP-HPLC method was validated as per International Council for Harmonisation (ICH) Q2 (R1) guidelines. The developed method showed linearity R² = 0.999 with a 0.5-20 µg/ml range. The Limit of Detection (LOD) and Limit of Quantification (LOQ) were 95 and 125 ng/ml, respectively. The accuracy and precision for the developed method came under the acceptance criteria. The developed method was used to evaluate the enhancement of solubility of the prepared PTX-β-CD complex. The method was also used in the evaluation of % drug loading, % drug release and stability of the PTX-β-CD complex. The study clearly showed that the solubility of PTX increased from 0 to 1.14± 0.53 µg/ml at pH 1.2 and 0 to 3.18± 0.61 µg/ml at pH 6.8, respectively. The PTX-β-CD complex showed 73± 3.75% drug release in 120 minutes at pH 1.2 and 87± 3.51% at pH 6.8. The developed RP-HPLC method was found to be eco-friendly as per the Analytical Greenness (AGREE) metric approach and software analysis.

Conclusion: An eco-friendly RP-HPLC analytical method was successfully developed and optimized for the quantification of PTX from the PTX-β-CD complex

Downloads

Download data is not yet available.

References

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17–48. doi: 10.3322/caac.21763.

Nygren P. What is cancer chemotherapy? Acta Onco. 2001;40(2–3):166–74. doi: 10.1080/02841860151116204.

Sudhakar A. History of cancer, Ancient and modern treatment methods. J of Cancer Sci & The. 2009;01(02):i–iv. doi: 10.4172/1948-5956.100000e2.

Gupta A, Nishchaya K, Saha M, Naik GARR, Yadav S, Srivastava S, Roy AA, Moorkoth S, Mutalik S, Dhas N. Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer. J of Drug Del Sci and Tech. 2024 Jan 25;105401. doi: 10.1016/j.jddst.2024.105401.

Barbuti A, Chen ZS. Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy. Cancers. 2015 Dec 3;7(4):2360–71. doi: 10.3390/cancers7040897.

Mohammadi A, Esmaeili F, Dinarvand R, Atyabi F, Walker RB. Development and validation of a stability-indicating method for the quantitation of paclitaxel in pharmaceutical dosage forms. J of Chroma Sci. 2009;47(7):599–604. doi: 10.1093/chromsci/47.7.599.

Gala UH, Miller DA, Williams RO. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochim biophys acta rev cancer. 2020;1873(1):188319. doi: 10.1016/j.bbcan.2019.188319.

Sharma S, Verma A, Teja BV, Shukla P, Mishra PR. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies. Eur J of Pharma Sci. 2015;69:51–60. doi: 10.1016/j.ejps.2014.11.012.

Vijayakumar A, Sharon E, Teena J, Nobil S, Nazeer I. A clinical study on drug-related problems associated with intravenous drug administration. J of Bas and Clin Pharma. 2014;5(2):49. doi: 10.4103/0976-0105.134984.

Tiwari G, Tiwari R, Rai AK. Cyclodextrins in delivery systems: Applications. J Pharm Bioallied Sci. 2010;2(2):72–9. doi: 10.4103/0975-7406.67003

Iacovino R, Caso J, Donato C, Malgieri G, Palmieri M, Russo L, Isernia C. Cyclodextrins as Complexing Agents: Preparation and Applications. Cur Org Chem. 2016;21(2):162–76. doi: 10.2174/1385272820666160909111842.

Ye YJ, Wang Y, Lou KY, Chen YZ, Chen R, Gao F. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Int J of Nanome. 2015;10:4309–19. doi: 10.2147/IJN.S83508.

Shah M, Shah V, Ghosh A, Zhang Z, Minko T. Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments. J Pharm Pharmacol (Los Angel). 2015 Jan 10;2(2):8. doi: 10.13188/2327-204X.1000011.

Liang N, Yan C, Liu Z, Hu W, Jiang K, Li G, Sun S. Functionalized hydroxypropyl-β-cyclodextrin derivative as a versatile nanovehicle for delivery of paclitaxel. J of Pol Sci. 2024;62(11):2399–409. doi: 10.1002/pol.20230833.

Mutalik SP, Mullick P, Pandey A, Kulkarni SS, Mutalik S. Box–Behnken design aided optimization and validation of developed reverse phase HPLC analytical method for simultaneous quantification of dolutegravir sodium and lamivudine co‐loaded in nano‐liposomes. J Sep Sci. 2021 Aug;44(15):2917–31. doi: 10.1002/jssc.202100152.

Naik S, Mullick P, Mutalik SP, Hegde AR, Lewis SA, Bhat K, Rao BSS, Mutalik S. Full Factorial Design for Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Timolol Maleate in Surfactant-Based Elastic Nano-Vesicular Systems. J Chromatogr Sci. 2022 Jul 12;60(6):584–94. doi: 10.1093/chromsci/bmab101.

Gupta A, Navti PD, Mutalik S, Saha M, Moorkoth S. DoE Guided Development of an HPLC Method for Evaluation of Amoxicillin and Metronidazole Co-loaded Mucoadhesive GRDDS Formulation for H. pylori Eradication. Chromatographia. 2023 Dec 1;86(11):729–42. doi: 10.1007/s10337-023-04290-z.

Kothawade SN, Pande VV. Development and validation of an rp-hplc method for deferiprone estimation in pharmaceutical dosage form. Asian J of Pharma and Cli Res. 2023 Apr 7;100–3. doi: 10.22159/ajpcr.2023v16i4.47000.

Salwa, Kumar L. Quality-by-design driven analytical method (AQbD) development and validation of HPLC–UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies. Micro J. 2023 Oct 1;193:108944. doi: 10.1016/j.microc.2023.108944.

Pavani Y, Aravind S, Annam C, Rao MS. Quantification and quality control of triple-drug combination employed for gastric ulcer using stability-indicating selective rp-hplc technique. Int J of App Pharma. 2024 May 7;140–8. doi: 10.22159/ijap.2024v16i3.50320.

Saha M, Gupta A, Shetty S, Mutalik S, Nandakumar K, Raghu Chandrashekar H, Dhas N, Moorkoth S. DoE-Aided Optimization of RP-HPLC Method for Simultaneous Estimation of Amoxicillin and Tinidazole Loaded Mucoadhesive GRDDS Formulation for the Treatment of H. pylori. Chromatographia. 2024 Jul;1-16. 2.doi: 10.1007/s10337-024-04346-8.

Huang J, Pu J, Yang Z, Zhang S, Zhang Z, Lu Q, Song D, Li X, Fang Z, Liu Y, Hu B. Development of a Syzygium aromaticum, L. essential oil/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation. Ind Crops and Prod. 2024 Aug 1;214:118500. doi: 10.1016/j.indcrop.2024.118500.

Zhang Y, Li F, Guo G, Xiu Y, Yan H, Zhao L, Gao S, Ye F, Fu Y. Preparation and characterization of betulin/methyl-beta-cyclodextrin inclusion complex electrospun nanofiber: Improving the properties of betulin. Ind Crops and Prod. 2024 Mar 1;209:117974. doi: 10.1016/j.indcrop.2023.117974.

Singh RK, Deora AS. An adduct: 5-fluorouracil incorporated β-cd inclusion complex for solubility and stability enhancement in dosage forms. Int J of App Pharma. 2022 Mar 7;286–92. doi: 10.22159/ijap.2022v14i2.43602.

Hussein K, Türk M, Wahl MA. Drug loading into β-cyclodextrin granules using a supercritical fluid process for improved drug dissolution. Eur J of Pharma Sci. 2008 Mar 3;33(3):306–12. doi: 10.1016/j.ejps.2008.01.003.

Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes. Molecules: A J of Syn Chem and Nat Prod Chem. 2018 May;23(5);1161. doi: 10.3390/molecules23051161.

Marques HMC, Hadgraft J, Kellaway IW. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J of Pharma. 1990 Sep 30;63(3):259–66. doi: 10.1016/0378-5173(90)90132-N.

Bennani I, Yachi L, Chefchaouni AC, Hafidi Y, Moukafih B, Marrakchi SE, Bandadi FZ, Fahry A, Alaoui YE, Bouatia M, Laatiris A, Cherkaoui N, Kartouti AE, Rahali Y. Solubilization Improvement using Non-Ionic Surfactants and Phospholipids Optimized by An Experimental Design: Case of Albendazole. Res J of Phar and Tech. 2024 May 15;17(5):1995–2000. doi: 10.52711/0974-360X.2024.00316.

Dua K, Pabreja K, Ramana MV, Lather V. Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac. J Pharm Bioallied Sci. 2011;3(3):417–25. doi: 10.4103/0975-7406.84457.

Pardhi VP, Patel P, Vaish A, Jain K. Inclusion complexes of bedaquiline fumarate with β-cyclodextrin and its derivatives: In silico, in vitro and in vivo evaluation. J of Drug Del Sci and Tech. 2024 Jan 1;91:105253. doi: 10.1016/j.jddst.2023.105253.

Hamid MHM, Elsaman T. A Stability-Indicating RP-HPLC-UV Method for Determination and Chemical Hydrolysis Study of a Novel Naproxen Prodrug. J of Chem. 2017 Oct 25;2017:e5285671. doi: 10.1155/2017/5285671.

Aiassa V, Garnero C, Zoppi A, Longhi MR. Cyclodextrins and Their Derivatives as Drug Stability Modifiers. Pharmaceuticals (Basel). 2023 Jul 28;16(8):1074. doi: 10.3390/ph16081074.

Zaman B, Hassan W, Khan A, Mushtaq A, Ali N, Bilal M, Ahmed DA. Forced Degradation Studies and Development and Validation of HPLC-UV Method for the Analysis of Velpatasvir Copovidone Solid Dispersion. Antibiotics (Basel). 2022 Jul 5;11(7):897. doi: 10.3390/antibiotics11070897.

Alsarra IA, Ahmed MO, Alanazi FK, ElTahir KEH, Alsheikh AM, Neau SH. Influence of Cyclodextrin Complexation with NSAIDs on NSAID/Cold Stress-Induced Gastric Ulceration in Rats. Int J Med Sci. 2010 Jul 5;7(4):232–9. doi:10.7150/ijms.7.232.

Goyal PK, Jaimini M. Development and validation of stability indicating rp-hplc method for quantitative estimation of metoprolol succinate and azelnidipine from synthetic mixture. J of Pharma Neg Res. 2023 Feb 6;772–9. doi: 10.47750/pnr.2023.14.03.101.

Gupta A, Navti PD, Mutalik S, Saha M, Moorkoth S. DoE Guided Development of an HPLC Method for Evaluation of Amoxicillin and Metronidazole Co-loaded Mucoadhesive GRDDS Formulation for H. pylori Eradication. Chromatographia. 2023 Oct 28; 86(11):729-42. doi: 10.1007/s10337-023-04290-z

Diamantis DA, Ramesova S, Chatzigiannis CM, Degano I, Gerogianni PS, Karadima KE, Perikleous S, Rekkas D, Gerothanassis IP, Galaris D, Mavromoustakos T, Valsami G, Sokolova R, Tzakos AG. Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulus. Biochi et Bio Acta (BBA) - Gen Sub. 2018 Sep 1;1862(9):1913–24. doi: 10.1016/j.bbagen.2018.06.006.

Emanuelli J, Eva Scherman Schapoval E. Stability-Indicating HPLC method for estimation of omarigliptin in tablets – Oxidative and photolytic kinetics and degradation products formed under oxidative conditions. Micro J. 2020 Sep 1;157:105084. doi: 10.1016/j.microc.2020.105084.

Carlotti ME, Sapino S, Ugazio E, Caron G. On the complexation of quercetin with methyl-β-cyclodextrin: photostability and antioxidant studies. J Incl Phenom Macrocycl Chem. 2011 Jun 1;70(1):81–90. doi: 10.1007/s10847-010-9864-7.

Vianna RFL, Bentley MVLB, Ribeiro G, Carvalho FS, Neto AF, de Oliveira DCR, Collett JH. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int J of Pharma. 1998 Jun 1;167(1):205–13. doi: 10.1016/S0378-5173(98)00068-4.

Peraman R, Lalitha KV, Raja NM, Routhu HB. Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms. Sci Pharm. 2014;82(2):281–93. doi: 10.3797/scipharm.1310-01.

Connors KA. The Stability of Cyclodextrin Complexes in Solution. Chem Rev. 1997 Aug 1;97(5):1325–58. doi: 10.1021/cr960371r.

Huang J, Fang Z, Bai C, Mo Y, Liu D, Yang B, Jia X, Feng L. Novel nano-encapsulated limonene: Utilization of drug-in-cyclodextrin-in-liposome formulation to improve the stability and enhance the antioxidant activity. Int J of Pharma. 2024 Mar 25;653:123914. doi: 10.1016/j.ijpharm.2024.123914.

Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE—Analytical GREEnness Metric Approach and Software. Anal Chem. 2020 Jul 21;92(14):10076–82. doi: 10.1021/acs.analchem.0c01887.

Raveendran A, Gupta A, Lewis LE, Prabhu K, Moorkoth S. A comprehensive approach for detection of biotin deficiency from dried blood spot samples using liquid chromatography-mass spectrometry. Future Sci OA. 2024 Dec 31;10(1):2355038. doi: 10.1080/20565623.2024.2355038.

Badea I, Ciutaru D, Lazar L, Nicolescu D, Tudose A. Rapid HPLC method for the determination of paclitaxel in pharmaceutical forms without separation. J of Pharma and Bio Anal. 2004 Feb 18;34(3):501–7. doi: 10.1016/s0731-7085(03)00628-9.

Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Kashaw S, Jain SK. Development and Validation of the HPLC Method for Simultaneous Estimation of Paclitaxel and Topotecan. J of Chrom Sci. 2014 Aug 1;52(7):697–703. doi: 10.1093/chromsci/bmt101.

Choudhury H, Gorain B, Karmakar S, Pal TK. Development and Validation of RP-HPLC Method: Scope of Application in the Determination of Oil Solubility of Paclitaxel. J of Chrom Sci. 2014 Jan 1;52(1):68–74. doi: 10.1093/chromsci/bms206.

Xavier Junior FH, Gueutin C, do Vale Morais AR, do Nascimento Alencar E, do Egito EST, Vauthier C. HPLC Method for the Dosage of Paclitaxel in Copaiba Oil: Development, Validation, Application to the Determination of the Solubility and Partition Coefficients. Chromatographia. 2016 Apr 1;79(7):405–12. doi: 10.1007/s10337-016-3058-4.

Sadeghi-Oroumiyeh A, Valizadeh H, Zakeri-Milani P. Determination of Paclitaxel Solubility and Stability in the Presence of Injectable Excipients. Pharma Chem J. 2021 Dec 1;55(9):983–8. doi: 10.1007/s11094-021-02526-6.

Velázquez NS, Ferreyra MG, Mengatto LN, Santagapita PR, Buera MP, Luna JA. Paclitaxel/β-Cyclodextrin interactions, a perspective from pulsed NMR spectroscopy experiments. Carb Res. 2019 Dec 1;486:107828. doi: 10.1016/j.carres.2019.107828.

Weng J, Tong HHY, Chow SF. In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method. Pharmaceutics. 2020 Aug 4;12(8):732. doi: 10.3390/pharmaceutics12080732.

Bouquet W, Ceelen W, Fritzinger B, Pattyn P, Peeters M, Remon JP, Vervaet C. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion – Formulation and stability. Eur Journal of Pharma and Biopharm. 2007 Jun 1;66(3):391–7. doi: 10.1016/j.ejpb.2006.11.025.

Parrenne L, Ribier Z, Abisror J, Cadix J, Benoit G, Bordenave J. Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins. Eur J Hosp Pharm. 2024 Jul 1;31(4):363–8. doi: 10.1136/ejhpharm-2022-003487.

Demir İ, Bulduk İ, Darwısh IA, Enginar H. A green approach for metoclopramide quantification in pharmaceutical products: new HPLC and spectrophotometric methods. Sci Rep. 2024 Apr 16;14(1):8765. doi: 10.1038/s41598-024-59149-6